ibandronic acid has been researched along with Liver Cirrhosis, Biliary in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerdá, D; Gifre, L; Guañabens, N; Monegal, A; Muxí, Á; Parés, A; Peris, P | 1 |
| Lindor, KD; Petz, JL; Silveira, MG; Treeprasertsuk, S | 1 |
| Bjelakovic, G; Giljaca, V; Gluud, C; Krstic, MN; Rudic, JS | 1 |
1 review(s) available for ibandronic acid and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Ibandronic Acid; Liver Cirrhosis, Biliary; Male; Osteoporosis; Randomized Controlled Trials as Topic | 2011 |
1 trial(s) available for ibandronic acid and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis.
Topics: Administration, Oral; Aged; Alendronate; Bone Density; Diphosphonates; Drug Administration Schedule; Female; Fractures, Bone; Humans; Ibandronic Acid; Liver Cirrhosis, Biliary; Middle Aged; Osteoporosis, Postmenopausal; Patient Compliance; Treatment Outcome | 2013 |
1 other study(ies) available for ibandronic acid and Liver Cirrhosis, Biliary
| Article | Year |
|---|---|
Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Liver Cirrhosis, Biliary; Male; Middle Aged; Osteoporosis; Pamidronate; Retrospective Studies; Zoledronic Acid | 2011 |